Jack Taylor reposted this
Bioniq is disrupting the one-size-fits-all supplement market. The personalized supplement maker closed a $15M oversubscribed Series B round led by European VCs Principal Investors HV Capital and Unbound. Valued at $75M, Bioniq turns blood biomarker data into individualized supplements. Its patent-pending algorithm assesses height, weight, age, lifestyle, and health goals to precisely identify micronutrient imbalances and create tailor-made supplements. Quantifying progress with before-and-after snapshots, Bioniq is setting a new industry-wide standard in transparency.
We’re on a journey towards better (and personalized) health Vadim Fedotov 🚀
CMO - Brand Builder - Innovator - 50 Women to Watch
2moOne size fits all just doesn't cut it.